COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

November 3, 2020

COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

Although Pfizer started clinical trials with a goal of releasing data by the beginning of November, that has become unlikely. CEO Albert Bourla announced that the company doesn’t anticipate sharing information on its trial until about a week after the data and safety monitoring board conducts its review of the company’s phase three vaccine trial. Yourway has two decades of experience and a robust global footprint, which allows us to deliver faster turnaround times.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?